e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Hostettler Katrin E., Halter Jörg P., Gerull Sabine, Lardinois Didier, Savic Spasenija, Roth Michael, Tamm Michael
Source:
Eur Respir J 2014; 43: 221-232
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hostettler Katrin E., Halter Jörg P., Gerull Sabine, Lardinois Didier, Savic Spasenija, Roth Michael, Tamm Michael. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. Eur Respir J 2014; 43: 221-232
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Acute viral bronchiolitis and acute asthma
Management of bronchiolitis for winter 2017/2018-What is in and what is out)
Acute bronchiolitis – prevention, diagnosis, and new approaches to management
Related content which might interest you:
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007
Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Eur Respir J 2008; 32: 670-677
Year: 2008
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004
Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant
Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017
Year: 2018
Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet?
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55
Year: 2004
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 179s
Year: 2004
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008
Protein profiling in two different phenotypes of bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010
Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004
Bronchiolitis obliterans syndrome (BOS) after bone marrow transplantation (BMT) in childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 144s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept